Hypertension prevalence, awareness, treatment, and control in 115 rural and urban communities involving 47 000 people from China

Journal of Hypertension

Volumn 34, Issue 1, 2016, Pages 39-46

  Li, Wei ^a,f   Gu, Hongqiu ^a   Teo, Koon K ^b   Bo, Jian ^a,f   Wang, Yang ^a,f   Yang, Jingang ^a   Wang, Xingyu ^c,f,x   Zhang, Hongye ^a,d,f   Sun, Yi ^a,f   Jia, Xuan ^a,f   He, Xinye ^a,f   Zhao, Xiuwen ^a,c,f   Cheng, Xiaoru ^a,f   Li, Jian ^c,f   Rangarajan, Sumathy ^b   Chen, Chunming ^e,f   Yusuf, Salim ^b   Liu, Lisheng ^a,d,f   Liu, Bing ^f   Hu, Bo ^f   Jin, Guo ^f   Chen, Hui ^f   Yang, Jun ^f   Wang, Kean ^f   Zhang, Li ^f   Deng, Qing ^f   Bing, Ren ^f   Chen, Tao ^f   Xu, Tao ^f   Wang, Wei ^f   Zhao, Wenhua ^f   Chang, Xiaohong ^f   Hou, Xixin ^f   Bai, Xiulin ^f   Liu, Xu ^f   Zhai, Yi ^f   Li, Dong ^g   Chen, Di ^g   Jin, Hui ^g   Tian, Jiwen ^g   Ma, Yumin ^g   Li, Yindong ^h   He, Chao ^h   You, Kai ^h   Zhang, Songjian ^h   Tian, Xiuzhen ⁱ   Xu, Xu ⁱ   Di, Jinling ⁱ   Wu, Jianquan ⁱ   Wang, Mei ^i,aa   Zhou, Qiang ⁱ   Zhang, Shiying ^j   Han, Aiying ^j   Cao, Minzhi ^j   Wu, Jianfang ^k   Jiang, Weiping ^k   Qiang, Deren ^k   Qin, Jing ^k   Qian, Shan ^k   Shi, Suyi ^k   Zhou, Yihong ^k   Qian, Zhenzhen ^l   Liu, Zhengrong ^l   Dong, Changlin ^m   Wan, Ming ^m   Li, Jun ^n,o   Tang, Jinhua ⁿ   Mo, Yongzhen ^o   Bian, Rongwen ^o   Lou, Qinglin ^o   Lei, Rensheng ^p   Hu, Lihua ^p   Xiong, Shuwei ^p   Zhong, Yan ^p   Li, Ning ^q   Tang, Xincheng ^q   Ye, Shuli ^q   Liu, Yu ^r   Li, Chunyi ^r   Li, Yujin ^r   Fu, Minfan ^s   Wang, Qiuyang ^s   Fu, Xiaoli ^s   Xing, Xiaojie ^t   Guo, Baoxia ^t   Feng, Huilian ^t   Xu, Lihui ^t   Yang, Yuqing ^u   Wu, Haibin Ma Ruiqi ^u   Wang, Yali ^u   Ma, Xiaolan ^v   Liu, Hongze ^v   Ma, Yurong ^v   Liao, Xiaoyang ^w   Yuan, Bo ^w   Zhao, Qian ^w   Xu, Guofan ^x   He, Hui ^x   Liu, Jiankang ^x   Chen, Ming ^y   Deng, Wenqing ^y   Lu, Fanghong ^z   Liu, Zhendong ^z   Zhang, Hua ^z   Sun, Shangwen ^z   Wang, Shujian ^z   Zhao, Yingkin ^z   Diao, Yutao ^z   Shi, Xuezheng ^aa   Ren, Debin ^x   Wei, Chuanrui ^x   Zhang, Liangqing ^ab   Wang, Jufang ^ab   Fan, Lianghou ^ac   Liu, Guoqin ^ac   Hou, Yan ^ad   Wu, Cuiying ^ad   Ma, Guilan ^ad   Wei, Hua ^ad   Wang, Junying ^ad   Bao, Xiongfei ^ad   Tang, Yue ^ad   Liu, Tianlu ^ae   Zhi, Yahong ^ae   Zhang, Peng ^af   Wang, Ailing ^af   Wang, Huijuan ^af   Liu, Jianna ^af   Liu, Qinzhou ^af   Wang, Rong ^af   Wu, Jianguo ^ag   Aili, Aideer ^ag   Wula, Ayoufumiti ^ag   Bula, Aibi ^ag   Yang, Dongmei ^ag   Wen, Qian ^ag   Reshalaiti, ^ag   Xiao, Yize ^ah   Shi, Qingping ^ah   Shao, Ying ^ah   He, Jing ^ai   Li, Kehua ^ai   Bai, Wuba ^ai   Yang, Jinkui ^ai   Jiang, Yunchun ^aj   Liu, Huaxing ^aj   Yang, Shunyun ^aj   more..

^a FUWAI HOSPITAL   (China)

^b MCMASTER UNIVERSITY   (Canada)

^c Laboratory of Human Genetics   (China)

^d Beijing Hypertension League Institute   (China)

^e Institute of Occupational Health and Poison Control   (China)

^f China Coordination Center Beijing Office   (China)

^g Jishuitan Orthopaedic College of Tsinghua University   (China)

^h CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

ⁱ Department of Internal Medicine   (China)

^j Center for Disease Control and Prevention of Bayannaoer   (China)

^k Wujin Center for Disease Control and Prevention   (China)

^l Jiangxinzhou Community Health Service Center of Nanjing   (China)

^m Department of Laboratory Science   (China)

ⁿ Nanjing Xiaohang Hospital   (China)

^o BEIJING HOSPITAL   (China)

^p Center for Disease Control and Prevention of Nanchang County   (China)

^q Qingshan Lake Community Health Service Station of Nanchang   (China)

^r No 242 Hospital   (China)

^s Daxing District Health Center of Shenyang   (China)

^t Shenyang Red Cross Hospital   (China)

^u Center for Disease Control and Prevention of Xining   (China)

^v Huizu Hospital of Xining   (China)

^w SICHUAN UNIVERSITY   (China)

^x Jianshe Road Health Center of Chengdu ^*  (China)

^y Dayi Caichang Town Health Center of Sichuan Province   (China)

^z Shandong Cardiovascular Research Institute   (China)

^aa Jinan Qiluhuayuan Hospital   (China)

^ab Shanxi Cardiovascular Hospital   (China)

^ac Peoples Hospital of Jingle County   (China)

^ad Balingqiao Community Healthcare Center of Taiyuan   (China)

^ae XIDIAN UNIVERSITY   (China)

^af Guanshan Hospital of Yanliang District   (China)

^ag Center for Disease Control and Prevention of Hetian   (China)

^ah YUNNAN PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^ai Damenglong Health Center of Xishuangbanna   (China)

^aj Center for Disease Control and Prevention of Mengla County   (China)

more..

Author keywords

awareness; China; control; hypertension; prevalence; region; rural versus urban communities; treatment

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ANTIHYPERTENSIVE AGENT; HERBACEOUS AGENT;

ADULT; AGE; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; AWARENESS; CHINA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EDUCATION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RURAL POPULATION; SEX DIFFERENCE; URBAN POPULATION; ATTITUDE TO HEALTH; BLOOD PRESSURE; COMBINATION DRUG THERAPY; MIDDLE AGED; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CHINA; DRUG THERAPY, COMBINATION; DRUGS, CHINESE HERBAL; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE; RURAL POPULATION; URBAN POPULATION;

EID: 84950160940     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000745     Document Type: Article

References (29)

1. World Health Organization. World health statistic 2012 [R]. Geneva: World Health Organization; 2006.
2. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2095-2128.
3. Hu SS, Kong LZ, Gao RL, Zhu ml, Wang W, Wang YJ, et al. Outline of the report on cardiovascular disease in China, 2010. Biomed Environ Sci 2012; 25:251-256.
4. Reynolds K, Gu D, Muntner P, Wu X, Chen J, Huang G, et al. Geographic variations in the prevalence, awareness, treatment and control of hypertension in China. J Hypertens 2003; 21:1273-1281.
5. Wu Y, Huxley R, Li L, Anna V, Xie G, Yao C, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation 2008; 118:2679-2686.
6. Wang J, Ning X, Yang L, Lu H, Tu J, Jin W, et al. Trends of hypertension prevalence, awareness, treatment and control in rural areas of northern China during 1991-2011. J Human Hypertens 2014; 28:25-31.
7. Xu B, Xu Z, Xu X, Cai Q, Xu Y. Prevalence, awareness, treatment, and control of hypertension among residents in Guangdong Province, China, 2004 to 2007. Circ Cardiovasc Qual Outcomes 2013; 6:217-222.
8. Wu Z, Yao C, Zhao D, Wu G, Wang W, Liu J, et al. Sino-MONICA project: a collaborative study on trends and determinants in cardiovascular diseases in China, Part i: morbidity and mortality monitoring. Circulation 2001; 103:462-468.
9. Meng XJ, Dong GH, Wang D, Liu MM, Lin Q, Tian S, et al. Prevalence, awareness, treatment, control, and risk factors associated with hypertension in urban adults from 33 communities of China: the CHPSNE study. J Hypertens 2011; 29:1303-1310.
10. Li YC, Wang LM, Jiang Y, Li XY, Zhang M, Hu N. Prevalence of hypertension among Chinese adults in 2010. Zhonghua yu fang yi xue za zhi [Chin J Prevent Med] 2012; 46:409-413.
11. Gao Y, Chen G, Tian H, Lin L, Lu J, Weng J, et al. Prevalence of hypertension in china: a cross-sectional study. PloS One 2013; 8:e65938.
12. Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 2013; 310:959-968.
13. Teo K, Chow CK, Vaz M, Rangarajan S, Yusuf S. The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. Am Heart J 2009; 158:1-7; e1.
14. Yusuf S, Islam S, Chow CK, Rangarajan S, Dagenais G, Diaz R, et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet 2011; 378:1231-1243.
15. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364:937-952.
16. Liu LS, Chen MQ, Zeng GY, Zhou BF. A forty-year study on hypertension. Zhongguo yi xue ke xue yuan xue bao 2002; 24:401-408.
17. Zhang M, Meng Y, Yang Y, Liu Y, Dong C, Xiao J, et al. Major inducing factors of hypertensive complications and the interventions required to reduce their prevalence: an epidemiological study of hypertension in a rural population in China. BMC Public Health 2011; 11:301.
18. Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P, et al. Prevalence, awareness, treatment, and control of hypertension in china. Hypertension 2002; 40:920-927.
19. Tao S, Wu X, Duan X, Fang W, Hao J, Fan D, et al. Hypertension prevalence and status of awareness, treatment and control in China. Chin Med J 1995; 108:483-489.
20. Wang Z, Wang X, Chen Z, Wang W, Zhu H, Chen W, et al. Hypertension control in community health centers across china: analysis of antihypertensive drug treatment patterns. Am J Hypertens 2013; 27:252-259.
21. Gao Y, Chen G, Tian H, Lin L, Lu J, Weng J, et al. Prevalence of hypertension in China: a cross-sectional study. PLoS One 2016; 8:e65938.
22. Wang J, Zhang L, Wang F, Liu L, Wang H, on behalf of the China National Survey of Chronic Kidney Disease Working Group. Prevalence, awareness, treatment, and control of hypertension in China: results from a National Survey. Am J Hypertens 2014; 27:1355-1361.
23. Li D, Lv J, Liu F, Liu P, Yang X, Feng Y, et al. Hypertension burden and control in Mainland China: analysis of nationwide data 2003-2012. Int J Cardiol 2015; 184:637-644.
24. Chou WL, Wang Z. Regional inequality in China's healthcare expenditures. Health Econ 2009; 18 (Suppl 2):S137-S146.
25. Khatib R, McKee M, Shannon H, Chow C, Rangarajan S, Teo K, et al. Availability and affordability of cardiovascular disease medicines and their impact on use: comparison across high, middle, and low-income countries. Lancet 2015; in press.
26. Liu LS. 2010 Chinese guidelines for the management of hypertension. Zhonghua xin xue guan bing za zhi 2011; 39:579-615.
27. Chalmers J, MacMahon S, Mancia G, Whitworth J, Beilin L, Hansson L, et al. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens 1999; 21:1009-1060.
28. Liu L, Wu Z, Zhang W, Zhang X, Li W. Strategies to improve blood pressure control level: from simple path to government participation. Chin J Hypertens 2014; 22:316-320.
29. Kjeldsen S, Feldman RD, Liu L, Mourad J-J, Chiang C-E, Zhang W, et al. Updated National and International Hypertension Guidelines: a review of current Recommendations. Drugs 2014; 74:2033-2051.